James C Mullen - Net Worth and Insider Trading
James C Mullen Net Worth
The estimated net worth of James C Mullen is at least $32 Million dollars as of 2024-04-25. James C Mullen is the CEO & President of Biogen Inc and owns about 131,149 shares of Biogen Inc (BIIB) stock worth over $27 Million. James C Mullen is the Director of Revvity Inc and owns about 45,551 shares of Revvity Inc (RVTY) stock worth over $5 Million. James C Mullen is also the Director of Insulet Corp and owns about 5,598 shares of Insulet Corp (PODD) stock worth over $919,024. Besides these, James C Mullen also holds Editas Medicine Inc (EDIT) . Details can be seen in James C Mullen's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that James C Mullen has not made any transactions after 2021-10-18 and currently still holds the listed stock(s).
Transaction Summary of James C Mullen
James C Mullen Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James C Mullen owns 6 companies in total, including Editas Medicine Inc () , Thermo Fisher Scientific Inc () , and Insulet Corp () among others .
Click here to see the complete history of James C Mullen’s form 4 insider trades.
Insider Ownership Summary of James C Mullen
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
Editas Medicine Inc | 2021-10-18 | director | |
Thermo Fisher Scientific Inc | 2018-11-07 | director | |
Insulet Corp | 2017-11-13 | director | |
Patheon NV | 2017-08-29 | director & Chief Executive Officer | |
Revvity Inc | 2014-11-14 | director | |
Biogen Inc | 2010-03-22 | director & CEO & President |
James C Mullen Latest Holdings Summary
James C Mullen currently owns a total of 4 stocks. Among these stocks, James C Mullen owns 131,149 shares of Biogen Inc (BIIB) as of March 22, 2010, with a value of $27 Million and a weighting of 81.89%. James C Mullen owns 45,551 shares of Revvity Inc (RVTY) as of November 14, 2014, with a value of $5 Million and a weighting of 14.34%. James C Mullen also owns 5,598 shares of Insulet Corp (PODD) as of November 13, 2017, with a value of $919,024 and a weighting of 2.83%. The other 1 stocks Editas Medicine Inc (EDIT) have a combined weighting of 0.93% among all his current holdings.
Latest Holdings of James C Mullen
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
BIIB | Biogen Inc | 2010-03-22 | 131,149 | 202.46 | 26,552,427 |
RVTY | Revvity Inc | 2014-11-14 | 45,551 | 102.09 | 4,650,302 |
PODD | Insulet Corp | 2017-11-13 | 5,598 | 164.17 | 919,024 |
EDIT | Editas Medicine Inc | 2021-10-18 | 57,673 | 5.22 | 301,053 |
Holding Weightings of James C Mullen
James C Mullen Form 4 Trading Tracker
According to the SEC Form 4 filings, James C Mullen has made a total of 0 transactions in Biogen Inc (BIIB) over the past 5 years. The most-recent trade in Biogen Inc is the sale of 440,500 shares on March 22, 2010, which brought James C Mullen around $26 Million.
According to the SEC Form 4 filings, James C Mullen has made a total of 0 transactions in Revvity Inc (RVTY) over the past 5 years. The most-recent trade in Revvity Inc is the sale of 8,892 shares on November 14, 2014, which brought James C Mullen around $388,847.
According to the SEC Form 4 filings, James C Mullen has made a total of 0 transactions in Insulet Corp (PODD) over the past 5 years. The most-recent trade in Insulet Corp is the acquisition of 2,500 shares on November 13, 2017, which cost James C Mullen around $168,625.
More details on James C Mullen's insider transactions can be found in the Insider Trading History of James C Mullen table.Insider Trading History of James C Mullen
- 1
James C Mullen Trading Performance
GuruFocus tracks the stock performance after each of James C Mullen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James C Mullen is -10.89%. GuruFocus also compares James C Mullen's trading performance to market benchmark return within the same time period. The performance of stocks bought by James C Mullen within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James C Mullen's insider trading performs compared to the benchmark.
Performance of James C Mullen
Average Return
-19.55%
Outperforming Transactions
50%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | 4.04 | -10.89 | 22.51 | -19.55 | -0.03 | 6.62 |
Relative Return to S&P 500(%) | 1.09 | -14.38 | 14.59 | -26.89 | -5.96 | -5.27 |
James C Mullen Ownership Network
Ownership Network List of James C Mullen
Ownership Network Relation of James C Mullen
James C Mullen Owned Company Details
What does Editas Medicine Inc do?
Who are the key executives at Editas Medicine Inc?
James C Mullen is the director of Editas Medicine Inc. Other key executives at Editas Medicine Inc include director & CEO Gilmore Neil O'neill , SVP & CHIEF MEDICAL OFFICER Baisong Mei , and EVP & Chief Business Officer Bruce Eaton .
Editas Medicine Inc () Insider Trades Summary
Over the past 18 months, James C Mullen made no insider transaction in Editas Medicine Inc (). Other recent insider transactions involving Editas Medicine Inc () include a net sale of 6,936 shares made by Bruce Eaton , a net sale of 7,365 shares made by Michelle Robertson , and a net sale of 84,310 shares made by Gilmore Neil O'neill .
In summary, during the past 3 months, insiders sold 98,151 shares of Editas Medicine Inc () in total and bought 0 shares, with a net sale of 98,151 shares. During the past 18 months, 126,045 shares of Editas Medicine Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 126,045 shares.
Editas Medicine Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Editas Medicine Inc Insider Transactions
James C Mullen Mailing Address
Above is the net worth, insider trading, and ownership report for James C Mullen. You might contact James C Mullen via mailing address: 940 Winter Street, Perkinelmer, Inc Legal Department, Waltham Ma 02451.